• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Biotherapeutics: Recent Developments using Chemical and Molecular Biology

Biotherapeutics: Recent Developments using Chemical and Molecular Biology

9781849736015
1,007.94 zł
907.14 zł Save 100.80 zł Tax included
Lowest price within 30 days before promotion: 907.14 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
This book illustrates the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text highlights recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book provides essential reading for medicinal and pharmaceutical chemists working in both industry and academia.
Product Details
77315
9781849736015
9781849736015

Data sheet

Publication date
2013
Issue number
1
Cover
hard cover
Pages count
336
Dimensions (mm)
156.00 x 234.00
Weight (g)
669
  • Synthetic Vaccines; Peptide Epitope Expressions; Carbohydrate vaccines; MicroRNA; Recent Advances in Antibody-Directed Conjugates; Selective Protein Modifications; Immunopharmacotherapy; Technologies being applied to B cell repertoire screening for Antibodies against Infectious Pathogens; Cyclotides and Cysteine-Knot Peptides; Phage Expression of Chemically-Constrained Cyclic Peptides; Nanobodies
Comments (0)